rs10483802
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006370.3(VTI1B):c.*681A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0605 in 1,612,962 control chromosomes in the GnomAD database, including 5,092 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.090 ( 866 hom., cov: 32)
Exomes 𝑓: 0.057 ( 4226 hom. )
Consequence
VTI1B
NM_006370.3 3_prime_UTR
NM_006370.3 3_prime_UTR
Scores
2
Splicing: ADA: 0.00004983
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.82
Publications
9 publications found
Genes affected
VTI1B (HGNC:17793): (vesicle transport through interaction with t-SNAREs 1B) Enables SNARE binding activity and chloride channel inhibitor activity. Involved in regulation of protein localization to plasma membrane. Located in several cellular components, including endosome membrane; lysosomal membrane; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
ARG2 (HGNC:664): (arginase 2) Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type II isoform encoded by this gene, is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood; it is thought to play a role in nitric oxide and polyamine metabolism. Transcript variants of the type II gene resulting from the use of alternative polyadenylation sites have been described. [provided by RefSeq, Jul 2008]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
- sulfite oxidase deficiency due to molybdenum cofactor deficiency type CInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
- hereditary hyperekplexiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.22 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VTI1B | NM_006370.3 | c.*681A>G | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000554659.6 | NP_006361.1 | ||
| ARG2 | NM_001172.4 | c.860-11T>C | intron_variant | Intron 7 of 7 | ENST00000261783.4 | NP_001163.1 | ||
| GPHN | XM_047430879.1 | c.1313-84491T>C | intron_variant | Intron 14 of 14 | XP_047286835.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VTI1B | ENST00000554659.6 | c.*681A>G | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_006370.3 | ENSP00000450731.1 | |||
| ARG2 | ENST00000261783.4 | c.860-11T>C | intron_variant | Intron 7 of 7 | 1 | NM_001172.4 | ENSP00000261783.3 | |||
| ARG2 | ENST00000557319.1 | n.534-11T>C | intron_variant | Intron 3 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0895 AC: 13620AN: 152106Hom.: 862 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13620
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0917 AC: 22971AN: 250396 AF XY: 0.0861 show subpopulations
GnomAD2 exomes
AF:
AC:
22971
AN:
250396
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0574 AC: 83847AN: 1460738Hom.: 4226 Cov.: 31 AF XY: 0.0575 AC XY: 41763AN XY: 726714 show subpopulations
GnomAD4 exome
AF:
AC:
83847
AN:
1460738
Hom.:
Cov.:
31
AF XY:
AC XY:
41763
AN XY:
726714
show subpopulations
African (AFR)
AF:
AC:
5127
AN:
33452
American (AMR)
AF:
AC:
9154
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
1089
AN:
26126
East Asian (EAS)
AF:
AC:
9152
AN:
39696
South Asian (SAS)
AF:
AC:
7908
AN:
86226
European-Finnish (FIN)
AF:
AC:
1364
AN:
53402
Middle Eastern (MID)
AF:
AC:
430
AN:
5074
European-Non Finnish (NFE)
AF:
AC:
45329
AN:
1111750
Other (OTH)
AF:
AC:
4294
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4207
8414
12620
16827
21034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2018
4036
6054
8072
10090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0898 AC: 13673AN: 152224Hom.: 866 Cov.: 32 AF XY: 0.0904 AC XY: 6733AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
13673
AN:
152224
Hom.:
Cov.:
32
AF XY:
AC XY:
6733
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
6229
AN:
41528
American (AMR)
AF:
AC:
2220
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
128
AN:
3470
East Asian (EAS)
AF:
AC:
1192
AN:
5170
South Asian (SAS)
AF:
AC:
441
AN:
4828
European-Finnish (FIN)
AF:
AC:
262
AN:
10612
Middle Eastern (MID)
AF:
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2917
AN:
68022
Other (OTH)
AF:
AC:
188
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
604
1208
1813
2417
3021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
576
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.